acetylphenylalanyl-prolyl-boroarginine has been researched along with refludan in 1 studies
Studies (acetylphenylalanyl-prolyl-boroarginine) | Trials (acetylphenylalanyl-prolyl-boroarginine) | Recent Studies (post-2010) (acetylphenylalanyl-prolyl-boroarginine) | Studies (refludan) | Trials (refludan) | Recent Studies (post-2010) (refludan) |
---|---|---|---|---|---|
30 | 0 | 0 | 368 | 27 | 54 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Callas, D; Fareed, J; Hoppensteadt, D; Kaiser, B; Mallinowska, K | 1 |
1 other study(ies) available for acetylphenylalanyl-prolyl-boroarginine and refludan
Article | Year |
---|---|
Comparative studies on the inhibitory spectrum of recombinant hirudin, DuP 714 and heparin on thrombin and factor Xa generation in biochemically defined systems.
Topics: Amino Acid Sequence; Antithrombin III; Boron Compounds; Cell-Free System; Enzyme Activation; Factor Xa; Heparin; Heparin, Low-Molecular-Weight; Hirudins; Humans; Molecular Sequence Data; Molecular Weight; Oligopeptides; Recombinant Proteins; Thrombin | 1994 |